IndraLab

Statements

AKT inhibits USP11. 1 / 1

| 1

reach

"LY294002 was used to treat U87-vIII, U251-vIII and N9-vIII cells, and PI3K and AKT pathway inhibition resulted in the transcriptional and translational upregulation of USP11."

31993801

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

AKT inhibits USP11. 1 / 1

INDRA sources:

Databases

Reading